Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 16, 2017JAMA OncologyOpen Access

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

View Full Paper
Ask AI
Bookmark
Share

Authors

EBEthan BaschADAmylou C. DueckLRLauren J. Rogak

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Basch et al. (2017) studied this question.

synapsesocial.com/papers/6a82b442979d337bd4440ef3https://doi.org/10.1001/jamaoncol.2016.6749
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The accuracy of pain and fatigue items across different reporting periods2008 · 304 citations
  2. 2Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)2014 · 1,173 citations
  3. 3Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)2015 · 1,045 citations
  4. 4Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms2016 · 336 citations
  5. 5The Measurement of Observer Agreement for Categorical Data1977 · 81,475 citations